Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Achieving Target Weight Patients who have reached their target weight and maintained it for a stable period (typically six months or more) may consider weaning down treatment
4 In Phase I studies, BI 3034701 demonstrated a generally favorable safety and tolerability profile, 10 a key factor in advancing the program into its next phase of clinical development
The first cost factor is the prescribed dose
These were tested first, followed by secondary endpoints in a predefined order, including achieving weight loss of at least 10% or 15% at week 104, and changes in waist circumference and systolic blood pressure from baseline to week 104
US$ 27.84
US$ 23.56
US$ 21.92
US$ 24.12
US$ 24.81
